Advertisement

Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 804–805 | Cite as

ASO Author Reflections: Even in Pancreatic Cancer, not all N Diseases are Created Equal

  • Eran NizriEmail author
  • Guy Lahat
  • Joseph Klausner
ASO Author Reflections
  • 37 Downloads

Notes

Disclosure

The authors have no conflicts of interest to disclose.

References

  1. 1.
    Basturk O, Saka B, Balci S, et al. Substaging of lymph node status in resected pancreatic ductal adenocarcinoma has strong prognostic correlations: proposal for a revised N classification for TNM staging. Ann Surg Oncol. 2015;22 Suppl 3:S1187–95.CrossRefGoogle Scholar
  2. 2.
    Nizri E, Sternbach N, Bar-David S, et al. T-Helper 1 immune response in metastatic lymph nodes of pancreatic ductal adenocarcinoma: a marker for prolonged survival. Ann Surg Oncol. Feb 2018;25(2):475–81.CrossRefGoogle Scholar
  3. 3.
    De Monte L, Reni M, Tassi E, et al. Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. J Exp Med. 2011;208(3):469–78.CrossRefGoogle Scholar
  4. 4.
    Nizri E, Greenman-Maaravi N, Bar-David S, et al. Analysis of histological and immunological parameters of metastatic lymph nodes from colon cancer patients reveals that T-helper 1 type immune response is associated with improved overall survival. Medicine (Baltimore). 2016;95(45):e5340.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Division of SurgeryTel-Aviv Sourasky Medical CenterTel AvivIsrael
  2. 2.Laboratory of Surgical OncologyTel-Aviv Sourasky Medical CenterTel AvivIsrael
  3. 3.Sackler Faculty of MedicineTel-Aviv UniversityTel AvivIsrael
  4. 4.The Nikolas and Elizabeth Shlezak Cathedra for Experimental Surgery, Sackler Faculty of MedicineTel-Aviv UniversityTel AvivIsrael

Personalised recommendations